As cancer cells or associated cells in the tumor microenvironment must express CCR2 at a high level, immunohistochemistry analysis of cancer tissue from patients may be needed and patients may have to be selected properly, in addition to previous confirmation of CCR2 expression in multiple cancer cell lines. This evidence concerns the gene CCR2 and neoplasm.